Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel, life-changing medicines for patients with debilitating diseases. Their research focuses on cardio-metabolic, liver, retinal, and oncologic diseases. NGM Bio aims to translate pioneering science into a pipeline of product candidates with the potential to significantly improve patient outcomes.
Serves as the central hub for research and development, clinical operations, corporate administration, and strategic decision-making for the company's biopharmaceutical programs.
Modern laboratory and office facilities equipped for advanced biologic drug discovery and development, fostering a collaborative research environment.
Characterized by a focus on scientific innovation, collaboration, and a commitment to addressing unmet medical needs. Employees are driven by research and the potential to impact patient lives within a dynamic, science-first environment.
Strategically located in South San Francisco, a leading global biotechnology cluster, providing access to a rich talent pool, research institutions, and potential collaborators essential for biopharmaceutical advancement.
NGM Biopharmaceuticals primarily operates from its headquarters in South San Francisco, California. While its core research, development, and corporate functions are centralized in the U.S., the company engages in global activities through clinical trials conducted at various international sites and may form strategic partnerships that extend its operational reach. Its drug development programs aim to address diseases with a global patient impact.
333 Oyster Point Blvd
South San Francisco
CA
United States
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, NGM Biopharmaceuticals' leadership includes:
NGM Biopharmaceuticals has been backed by several prominent investors over the years, including:
Over the past year, NGM Biopharmaceuticals has seen significant leadership transitions, including the appointment of a new permanent CEO and CFO, following departures in late 2023.
Discover the tools NGM Biopharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
NGM Biopharmaceuticals likely utilizes common corporate email formats. While exact structures can vary, a frequent pattern is the first initial followed by the last name.
[first_initial][last]@ngmbio.com
Format
dwoodhouse@ngmbio.com
Example
75%
Success rate
NGM Biopharmaceuticals Press Release • April 2, 2024
NGM Biopharmaceuticals announced the appointments of David J. Woodhouse, Ph.D., as President and Chief Executive Officer and Randy Schwab, M.B.A., as Chief Financial Officer, effective April 1, 2024. Both had been serving in these roles on an interim basis....more
NGM Biopharmaceuticals Press Release • March 7, 2024
NGM Biopharmaceuticals reported its financial results for the fourth quarter and full year ended December 31, 2023, and provided an update on its pipeline progress and corporate strategy....more
NGM Biopharmaceuticals Press Release • December 1, 2023
NGM Biopharmaceuticals presented encouraging preliminary safety and anti-tumor activity data from its Phase 1/1b trial of NGM707 in patients with advanced solid tumors....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including NGM Biopharmaceuticals, are just a search away.